Literature DB >> 26891445

Review of Cases and a Patient Report of Myiasis with Tracheostomy, Peru.

Virgilio E Failoc-Rojas, Heber Silva-Díaz.   

Abstract

Entities:  

Keywords:  Cochliomyia hominivorax; Peru; developing country; ectoparasitic infestations; larva; myiasis; parasites; screw worm infection; tracheostomy

Mesh:

Substances:

Year:  2016        PMID: 26891445      PMCID: PMC4766876          DOI: 10.3201/eid2203.151631

Source DB:  PubMed          Journal:  Emerg Infect Dis        ISSN: 1080-6040            Impact factor:   6.883


× No keyword cloud information.
To the Editor: Myiasis is the infestation in humans of larvae of flies (order Diptera). These larvae can infect skin, necrotic tissues, and natural cavities of living persons. Myiasis can be primary if it infects intact skin or secondary if it infects a previous injury. Depending on the degree of parasitism, myiasis may be obligatory (requiring a live host for parasite survival), facultative (developing in live or dead organic matter), or accidental (developing accidentally in an inappropriate host) (). In South America, the species that most frequently cause myiasis are Dermatobia hominis and Cochliomyia hominivorax. Factors contributing to development of myiasis are low socioeconomic status, unhealthy environments, advanced age, alcoholism, neurologic diseases, and lack of personal hygiene (,). Myiasis may occur different tissues, but reports of myiasis of the tracheal stoma are rare. We searched PubMed, MedLine, Lilacs, Scopus, and Google Scholar databases for scientific articles published in English or Spanish languages during 1990–2015 by using the search term “myiasis and tracheostomy.” We found reports of 10 patients (Table).
Table

Reports in the literature about myiasis associated with tracheostomy, by date of publication*

Country Patient age, y/sex Associated conditions Fly species Year of publication Reference†
Canada 85/FComatose state for 2 moUnidentified1993(3)
Italy 57/MPersistent vegetative state Lucilia caesar 2006(4)
Brazil 49/MNeck carcinoma Cochliomyia hominivorax 2011(5)
India 78/MTracheostomy by car accident Chrysomya bezziana 2011(6)
Argentina 8/NACerebral palsyUnidentified2012(7)
India 52/MLaryngeal cancerMusca domestica (housefly)2013(8)
India 73/NACarcinoma supraglottis and diabetes Chrysomya bezziana 2013(9)
Turkey 86/FPoor hygienic condition and tetraplegia Lucilia caesar 2014(10)
India 57/MProliferative ulcer on vocal cords and glottic stenosis Chrysomya bezziana 2015(11)
Italy 5/MWerdnig-Hoffmann disease Sarcophaga argyrostoma 2015(12)
Peru 67/MEsophageal cancer Cochliomyia hominivorax This study

*NA, not available.
†Sources: PubMed, Medline, Scopus, LILACS, and Google Scholar. References are in the .

*NA, not available.
†Sources: PubMed, Medline, Scopus, LILACS, and Google Scholar. References are in the . We also report a case of tracheostomal myiasis in a 67-year-old man from Túcume, Peru. The patient had a history of esophageal tumor lesion with considerable airway stenosis related to upper esophageal cancer (stage III). Six months before onset of myiasis, he had respiratory difficulty caused by obstructed airway and underwent a tracheostomy and gastrostomy. When the patient was admitted to the emergency department of a hospital in Lambayeque, located ≈35 km from the patient’s home, mobile larvae were present at the tracheostomy site, which also contained brown secretions with traces of blood and obvious signs of inflammation. A cervical abscess surrounded by necrotic tissue was visible, which, according to family members, developed after the larval infection. We manually removed the larvae and began treatment with ivermectin orally (1 dose, 200 µg/kg), ceftriaxone orally (2 g/d), and metronidazole intravenously (500 mg every 8 h). Three days after the patient started treatment, the tracheostomy tube was surgically removed for changing, and a large number of dead larvae were then observed and removed. The patient showed no signs of septicemia. He had slight relative eosinophilia (6%), but his hemoglobin and leukocyte levels were within reference ranges; the larvae would be unable to penetrate cells at these levels. The patient improved with no clinical symptoms of cervical abscess or evidence of phlogosis. He was discharged 9 days after admission, with a postdischarge treatment of oral metronidazole (500 mg every 12 h for 3 d). Three specimens of larvae were sent to the hospital’s parasitology laboratory, which identified the larvae as C. hominivorax stage L-3 (infection began with fly oviposition ≈6 days before admission; L-1, L-2, and L-3 are stages of larval development from hatching until pupation, requiring ≈7 days). The larvae were 10 mm × 3 mm and had a cylindrical, pale yellow body segmented with pigmented tracheal trunks visible in the last 4 posterior segments. Microscopic examination showed that the anterior end had a prominent jaw and segments with small bands of cuticular spines; the rear end had exposed spiracles, each with 3 straight grooves and open peritrematic membranes (reference 13 in the Technical Appendix). The life cycle of C. hominivorax is similar to any other species in the Diptera order. Open wounds and body orifices (e.g., a tracheostomy) emitting odors from natural secretions are conducive for oviposition by flies and development of myiasis. A study from Brazil mentions that open wounds are the leading cause of development of the C. hominivorax parasite (). Chronic extensive wounds are often infested by C. hominivorax (,). Myiasis infection is concerning because it can lead to secondary infections such as Escherichia coli, Serratia marcescens, and Enterococcus faecalis (). The infection is most dangerous when patients have concurrent conditions such as immunosuppression. Treatment of myiasis involves manual removal of larvae and surgical debridement, in conjunction with ivermectin and systemic broad-spectrum antimicrobial drugs to prevent secondary infections (,). Treatment with ivermectin can kill the larvae (; references 14,15 in the Technical Appendix) and result in considerable reduction of larvae in infested wounds. Ivermectin has a broad antiparasitic spectrum that causes immobilization of parasites by inducing tonic paralysis of the parasite’s muscles, mainly at the pharyngeal level, resulting in the death of the parasites by suffocation and starvation. For the patient in this report, the single oral dose (0.2 mg/kg) of ivermectin was an effective treatment for myiasis. However, to control the underlying disease and prevent recurrences, ivermectin should be used with oral antimicrobial drugs and wound care when the wound has a high number of larvae, which are associated with bacterial infections (,). For bedridden patients, patients with superficial wounds who live in myiasis-endemic areas, or patients who undergo a tracheostomy or have open wounds, health workers and caregivers should consider preventive care of wounds, which are risk factors for myiasis infection. This care consists of suitable wound dressing and proper personal and environmental hygiene.

Technical Appendix

Additional References
  8 in total

Review 1.  Unusual pseudomyiasis with Musca domestica (housefly) larvae in a tracheostomy wound: a case report and literature review.

Authors:  Mohammad Shakeel; Iram Khan; Imteyaz Ahmad; Zafar Iqbal; Syed Abrar Hasan
Journal:  Ear Nose Throat J       Date:  2013-07       Impact factor: 1.697

Review 2.  Myiasis.

Authors:  Fabio Francesconi; Omar Lupi
Journal:  Clin Microbiol Rev       Date:  2012-01       Impact factor: 26.132

3.  Myiasis of the tracheostomy wound: case report.

Authors:  R Franza; L Leo; T Minerva; F Sanapo
Journal:  Acta Otorhinolaryngol Ital       Date:  2006-08       Impact factor: 2.124

4.  An unusual nosocomial infection: nasotracheal myiasis.

Authors:  R L Josephson; S Krajden
Journal:  J Otolaryngol       Date:  1993-02

5.  Tracheostomal myiasis: a case report and review of the literature.

Authors:  S Prasanna Kumar; A Ravikumar; L Somu; P Vijaya Prabhu; Rajavel Mundakannan Subbaiya Periyasamy Subbaraj
Journal:  Case Rep Otolaryngol       Date:  2011-12-20

6.  Factors of susceptibility of human myiasis caused by the New World screw-worm, Cochliomyia hominivorax in São Gonçalo, Rio de Janeiro, Brazil.

Authors:  José A Batista-da-Silva; Gonzalo E Moya-Borja; Margareth M C Queiroz
Journal:  J Insect Sci       Date:  2011       Impact factor: 1.857

7.  Patient with tracheostomy parasitized in hospital by larvae of the screwworm, Cochliomyia hominivorax.

Authors:  José A Batista-da-Silva; Gonzalo E M Borja; Margareth M C Queiroz
Journal:  J Insect Sci       Date:  2011       Impact factor: 1.857

8.  Tracheostomy wound myiasis in a child: case report and review of the literature.

Authors:  J Blejter
Journal:  Case Rep Pediatr       Date:  2012-01-11
  8 in total
  4 in total

1.  Case Report: Myiasis due to Cochliomyia hominivorax and Dermatobia hominis: Clinical and Pathological Differences between Two Species in Northern Peru.

Authors:  Virgilio E Failoc-Rojas; Carolina Molina-Ayasta; Jaime Salazar-Zuloeta; Abel Samamé; Heber Silva-Díaz
Journal:  Am J Trop Med Hyg       Date:  2018-01-01       Impact factor: 2.345

2.  Prevalence of tracheopulmonary myiasis amidst humans.

Authors:  Amandeep Singh
Journal:  Parasitol Res       Date:  2020-11-27       Impact factor: 2.289

Review 3.  Intratracheal myiasis followed by tracheal-esophageal fistula: report of a rare case and literature review.

Authors:  Wendi Huang; Chao Zeng; Weidong Song; Ping Xu
Journal:  BMC Infect Dis       Date:  2019-12-17       Impact factor: 3.090

4.  Umbilical Myiasis by Cochliomyia hominivorax in an Infant in Colombia.

Authors:  Juan David Ruiz-Zapata; Luis Mauricio Figueroa-Gutiérrez; Jaime Alberto Mesa-Franco; Paula Andrea Moreno-Gutierrez
Journal:  Front Med (Lausanne)       Date:  2020-01-22
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.